The medical bionic implant and exoskeleton market is estimated to be worth US$ 742.0 million in 2023. The market has registered a valuation of US$ 690.2 million in 2022. From 2023 to 2033, the CAGR for the market is a solid 6.3%. By the end of the forecast period, the market is expected to have soared to US$ 1,361.90 million.
Key Analysis in the Medical Bionic Implant and Exoskeleton Market:
Minimally invasive surgeries provide a solid alternative to bionic implants. The emergence of minimally-invasive surgeries is thus marked to impede the growth of the medical bionic implant and exoskeleton market.
| Attributes | Details |
|---|---|
| Market Value for 2023 | US$ 742.0 million |
| Market Value for 2033 | US$ 1,361.90 million |
| CAGR of Market for 2023 to 2033 | 6.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The medical bionic implant and exoskeleton market was tipped to be US$ 519.4 million in value in 2018. The market likely progressed at a healthy CAGR of 7.4% from 2018 to 2022.
The popularity of bionic implants as a solution to replace missing body parts rose during the historical period. The pandemic resulted in several people suffering adverse medical conditions. Bionic implants were sought as a resort for people who lost body parts. By the end of the historical period in 2022, the medical bionic implant and exoskeleton market had reached a valuation of US$ 690.2 million.
| Market Valuation (2018) | US$ 519.4 million |
|---|---|
| Historical CAGR (2018 to 2022) | 7.4% |
| Historical Valuation (2022) | US$ 690.2 million |
For 2023, the value of the medical bionic implant and exoskeleton market is anticipated to be US$ 742.0 million. The growth of the market is predicted to be sturdy over the forecast period from 2023 to 2033, with a CAGR of 6.3%.
The popularity of bionic implants as a solution for missing body parts is expected to continue during the forecast period. The incidence of people getting injured or coming upon bodily harm is rising, necessitating bionic implants for proper functioning. Further, the number of people born with missing body parts is also increasing, leading to growth in the consumer base.
The market has to contend with the alternative of surgeries, though. Minimally invasive surgeries are becoming common, and many prefer surgery over bionic implants. By the end of the forecast period in 2033, the value of the market is predicted to have jumped to US$ 1,361.90 million.
Principal Consultant
The medical bionic implant and exoskeleton market can be bifurcated into two segments: product type and distribution channel. Looking at the segments, the body part most required to be replaced by bionic implants becomes clear. The mode through which bionic implants are put into bodies also becomes clear.
Bionic forelimbs/hand implants dominate the medical bionic implant and exoskeleton market. In 2023, bionic forelimbs/hand implants are expected to account for an overwhelming 58.5% of the market share by product type.
The loss of hands, whether partial or complete, can considerably constrict the functioning of people. Thus, the help of bionic forelimbs/hand implants is sought to replace missing hands or forelimbs. Injuries and accidents resulting in damage to arms also contribute to the prevalent demand for bionic forelimbs/hand implants.
| Attributes | Details |
|---|---|
| Top Product Type | Bionic Forelimbs/ Hand Bionics |
| Market Share in 2023 | 58.5% |
Prosthetic bionics hold a significant share of the market. In 2023, prosthetic bionics are anticipated to have a whopping 80.7% market share by distribution channel.
Prosthetic bionic limbs help connect the mind and the body, allowing for better functioning. Thus, the popularity of prosthetic bionics is marked to continue unabated in the future.
| Attributes | Details |
|---|---|
| Top Distribution Channel | Prosthetic Bionics |
| Market Share in 2023 | 80.7% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Asia Pacific is marked to be the region where the growth of the medical bionic implant and exoskeleton market is expected to be high. The region's rising population is one of the driving factors for the expected growth of the market in the region.
North America and Europe are two regions where the market has established a foothold. The progress in the two regions is marked to be slower than in the Asia Pacific, but opportunities still exist.
| Countries | CAGR (2023 to 2033) |
|---|---|
| United States | 2.8% |
| India | 9.4% |
| United Kingdom | 4.1% |
| Germany | 3.8% |
| China | 8.1% |
For the 2023 to 2033 forecast period, the CAGR for the United States is anticipated to be a consistent 2.8%. The increase in amputees as a result of accidents and injuries is leading to people in the United States resorting to bionic implants. However, there have also been controversies in the United States regarding bionic implants.
For example, Advanced Bionics LLC had to pay United States authorities US$ 11.36 million for certain misleading information provided regarding the entity's cochlear implants. Thus, while there is opportunity for the market in the United States, there are also specific challenges.
India is one of the most promising countries for the market. For the forecast period, the CAGR of India is projected to be an encouraging 9.4%.
The popularity of sports activities is increasing in India, which is aided by government initiatives. The rise in people actively participating in sports also leads to sports injuries. In addition, paralympic athletes who take the help of bionic implants are also gaining visibility in the country.
China is another Asian country where the market is expected to flourish. For the forecast period, the CAGR for China is projected to be a promising 8.1%.
The rise in the industrial landscape of China has also led to an increase in workplace injuries. Challenges such as operating heavy machinery are leading to accidents in China. Thus, the market is seeing many customers in the country.
The United Kingdom holds a moderate potential for the market. For the 2023 to 2033 period, the CAGR for the market in the United Kingdom is a steady 4.1%.
Technological advancements are endearing bionic implants to consumers in the United Kingdom. People in the United Kingdom are intrigued with technological innovations like mind-controlled and 3D-printed bionic implants.
Germany is another European country showing promise for the market. For the 2023 to 2033 period, the CAGR for Germany is estimated to be an average of 3.8%.
The population of Germany is aging fast. The rising senior population ensures the number of patients with damaged organs remains high in Germany. Thus, there is consistent demand for bionic implants in Germany.
The market for medical bionic implants and exoskeletons is relatively fragmented. Key players are implementing the strategy of partnerships and collaborations to have a competitive edge. Technology plays a key role when market players look for ambitious product improvements. By investing in technology, market players can measure implants' efficiency and functioning.
Recent Developments in the Medical Bionic Implant and Exoskeleton Market
The size of the market is estimated to be US$ 742.0 million in 2023.
The CAGR of the market is likely to record a growth of 6.3% from 2023 to 2033.
The market is expected to reach a valuation of US$ 1,361.90 million in 2033.
Otto Bock Inc., DJO Global Inc., and Ekso Bionics are prominent players in the market.
Mind-controlled bionic implants and the rise of sports injuries.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Bionic Forelimbs/Hand Bionics
5.3.1.1. Wrist Bionics
5.3.1.2. Bionic Elbow Braces
5.3.1.3. Bionic Limbs
5.3.1.4. Bionic Fingers
5.3.2. Bionic Legs/Lower Limbs
5.3.2.1. Bionic Knee Braces
5.3.2.2. Ankle Bionics
5.3.2.3. Bionic Foot Below Knee
5.3.3. Exoskeletons & Suits
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Mode, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Mode, 2023 to 2033
6.3.1. Prosthetic Bionics
6.3.2. External Bionics
6.4. Y-o-Y Growth Trend Analysis By Mode, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Mode, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product
8.2.3. By Mode
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product
8.3.3. By Mode
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product
9.2.3. By Mode
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Mode
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Product
10.2.3. By Mode
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Mode
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Product
11.2.3. By Mode
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Mode
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Product
12.2.3. By Mode
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Mode
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By Mode
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Mode
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product
14.2.3. By Mode
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Mode
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product
15.1.2.2. By Mode
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product
15.2.2.2. By Mode
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product
15.3.2.2. By Mode
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product
15.4.2.2. By Mode
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product
15.5.2.2. By Mode
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product
15.6.2.2. By Mode
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product
15.7.2.2. By Mode
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product
15.8.2.2. By Mode
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product
15.9.2.2. By Mode
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product
15.10.2.2. By Mode
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product
15.11.2.2. By Mode
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product
15.12.2.2. By Mode
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product
15.13.2.2. By Mode
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product
15.14.2.2. By Mode
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product
15.15.2.2. By Mode
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product
15.16.2.2. By Mode
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product
15.17.2.2. By Mode
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Product
15.18.2.2. By Mode
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Product
15.19.2.2. By Mode
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Product
15.20.2.2. By Mode
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Product
15.21.2.2. By Mode
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Product
15.22.2.2. By Mode
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Product
15.23.2.2. By Mode
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By Mode
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Otto Bock Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. DJO Global Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Ossur Corporate
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Ekso Bionics
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Rex Bionics Ltd.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Alter G
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. ReWalk Robotics
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Invacare
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Hill-Rom Services
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Medtronic PLC.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Mobius Bionics.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Boston Scientific Corporation
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Medical Bionic Implant and Exoskeleton Market
